Preprint · 2026 · Open access
Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol
Published 1 January 2026 · DOI 10.17605/osf.io/nwtcs
In brief
“Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol” is a 2026 preprint by Doménica Gabirela Escudero Samaniego and 7 co-authors. OpenAlex counts 1 citations as of 18 November 2026. It is open access: the full text is free to read at Open Science Framework.
- Citations
- 1
- Most cited in
- 2026 (1)
- Authors
- 8
Abstract
Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are widely used in the management of type 2 diabetes mellitus and obesity due to their proven benefits in glycemic control, weight reduction, and cardiovascular risk reduction (ALGHAMDI et al., 2025). As the use of agents such as semaglutide, liraglutide, and dulaglutide continues to expand globally, increasing attention has been directed toward potential adverse effects beyond the gastrointestinal system, including oral and salivary manifestations. Pharmacovigilance data and emerging studies suggest that GLP-1RA therapy may be associated with oral symptoms such as xerostomia, dysgeusia, oral hypoesthesia, and throat discomfort (ALMOHAMMAD et al., 2025), which may disrupt salivary function and oral homeostasis, potentially increasing the risk of dental caries, periodontal inflammation, and mucosal alterations (BARAĆ et al., 2025 ; SHANTHI et al., 2026). However, current evidence regarding these oral manifestations remains fragmented and is often reported as secondary outcomes across heterogeneous study designs and populations. Therefore, a scoping review is an appropriate approach to systematically map and synthesize the available evidence on oral manifestations including xerostomia, periodontal disease, caries risk, mucosal changes, and salivary flow alterations—among individuals treated with GLP-1 receptor agonists across diverse clinical and population-based settings. This review aims to identify the range of reported oral adverse effects, characterize the populations and contexts in which they occur, and highlight gaps in the existing literature to inform future research and clinical practice.
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Samaniego, D. G. E., Tarapués, M. A. F., Vergara, B. T. C., Stefani, C. M., Coelho, M. S., Gonçalves, T. M. S. V., Canto, G. D. L., & Pauletto, P. (2026). Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol. https://doi.org/10.17605/osf.io/nwtcs
MLA 9
Samaniego, Doménica Gabirela Escudero, et al. “Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol.” 2026. https://doi.org/10.17605/osf.io/nwtcs.
Chicago
Samaniego, Doménica Gabirela Escudero, Melany Abigail Falconí Tarapués, Bianca Taíz Cañarte Vergara, Cristine Miron Stefani, Manuella Salm Coelho, Thaís Marques Simek Vega Gonçalves, G. de Luca Canto, and Patrícia Pauletto. 2026. “Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol.” https://doi.org/10.17605/osf.io/nwtcs.
Harvard
Samaniego, D. G. E. et al. (2026) ‘Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol’. doi:10.17605/osf.io/nwtcs.
IEEE
D. G. E. Samaniego et al., “Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol,” 2026, doi: 10.17605/osf.io/nwtcs.
BibTeX
@misc{samaniego2026oral,
title = {{Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol}},
author = {Samaniego, Doménica Gabirela Escudero and Tarapués, Melany Abigail Falconí and Vergara, Bianca Taíz Cañarte and Stefani, Cristine Miron and Coelho, Manuella Salm and Gonçalves, Thaís Marques Simek Vega and Canto, G. de Luca and Pauletto, Patrícia},
year = {2026},
doi = {10.17605/osf.io/nwtcs},
url = {https://doi.org/10.17605/osf.io/nwtcs}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Topic and keywords
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- GLP-1 receptor agonists
- GIP receptor agonist
- oral manifestations
- xerostomia
- dysgeusia
- periodontal disease
- caries risk
- salivary flow
Work with this paper
Most-cited papers in Medicine
- Yaşlı Kadınlarda Üreme SağlığıDemet Kokanalı, Yaprak Engin Üstün · Jinekoloji-Obstetrik ve Neonatoloji Tıp Dergisi · 2019 · 169,630 citations
- Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 CountriesHyuna Sung, Adalberto M. Filho, Mathieu Laversanne and 5 more · CA A Cancer Journal for Clinicians · 2021 · 119,885 citations
- “Mini-mental state”Marshal F. Folstein, Susan E. Folstein, Paul R. McHugh · Journal of Psychiatric Research · 1975 · 90,424 citations
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countriesFreddie Bray, Jacques Ferlay, Isabelle Soerjomataram and 3 more · CA A Cancer Journal for Clinicians · 2018 · 87,396 citations
- Hallmarks of Cancer: The Next GenerationDouglas Hanahan, Robert A. Weinberg · Cell · 2011 · 69,758 citations
Questions about this paper
How do I cite this paper in APA style?
Samaniego, D. G. E., Tarapués, M. A. F., Vergara, B. T. C., Stefani, C. M., Coelho, M. S., Gonçalves, T. M. S. V., Canto, G. D. L., & Pauletto, P. (2026). Oral Manifestations Associated with GLP-1 and GIP Receptor Agonists: A Scoping Review Protocol. https://doi.org/10.17605/osf.io/nwtcs
How many times has this paper been cited?
1 times, according to OpenAlex on 18 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access at Open Science Framework: sign in and open the full text from this page.
Who wrote this paper?
Doménica Gabirela Escudero Samaniego, Melany Abigail Falconí Tarapués, Bianca Taíz Cañarte Vergara, Cristine Miron Stefani, Manuella Salm Coelho, Thaís Marques Simek Vega Gonçalves, G. de Luca Canto, Patrícia Pauletto.
What is the DOI of this paper?
10.17605/osf.io/nwtcs, permanently at https://doi.org/10.17605/osf.io/nwtcs. Sign in and open it from this page.
Bibliographic data from OpenAlex (CC0), last checked 18 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.